about
Multiple sclerosis: molecular mechanisms and therapeutic opportunitiesAu-ACRAMTU-PEt3 Alters Redox Balance To Inhibit T Cell Proliferation and FunctionCurrent and emerging therapies in multiple sclerosis: a systematic reviewLow-dose 5-aza-2'-deoxycytidine pretreatment inhibits experimental autoimmune encephalomyelitis by induction of regulatory T cellsIntestinal barrier dysfunction develops at the onset of experimental autoimmune encephalomyelitis, and can be induced by adoptive transfer of auto-reactive T cells.Search for cellular stress biomarkers in lymphocytes from patients with multiple sclerosis: a pilot studyHLA class I & II alleles in multiple sclerosis patients from Puerto Rico.Current and future immunomodulation strategies to restore tolerance in autoimmune diseases.Two discreet subsets of CD8 T cells modulate PLP(91-110) induced experimental autoimmune encephalomyelitis in HLA-DR3 transgenic mice.Thymic deletion and regulatory T cells prevent antimyeloperoxidase GN.PD-1 Interaction with PD-L1 but not PD-L2 on B-cells Mediates Protective Effects of Estrogen against EAETolerogenic vaccines for Multiple sclerosisEmerging immunopharmacological targets in multiple sclerosis.Glatiramer acetate attenuates the activation of CD4+ T cells by modulating STAT1 and -3 signaling in glia.CCR7 deficient inflammatory Dendritic Cells are retained in the Central Nervous SystemImmune privilege of the CNS is not the consequence of limited antigen sampling.Interferons as biomarkers and effectors: lessons learned from animal models.Pathogenic CD8 T cells in multiple sclerosis and its experimental models.Janus-faced microglia: beneficial and detrimental consequences of microglial phagocytosis.Modulation of IL-2Rα with daclizumab for treatment of multiple sclerosis.Antigen-specific tolerization approaches in multiple sclerosis.From the nucleus to the plasma membrane: translocation of the nuclear proteins histone H3 and lamin B1 in apoptotic microglia.Future view and development of immunology: exploring the immunology based on Chinese medicine and culture.Theiler's murine encephalomyelitis virus infection of SJL/J and C57BL/6J mice: Models for multiple sclerosis and epilepsy.Single nucleotide polymorphisms in the FOXP3 gene are associated with increased risk of relapsing-remitting multiple sclerosis.Superior isolation of antigen-specific brain infiltrating T cells using manual homogenization technique.Tolerance of activated pathogenic CD4+ T cells by transcriptional targeting of dendritic cells.Divergent Immunomodulation Capacity of Individual Myelin Peptides-Components of Liposomal Therapeutic against Multiple Sclerosis.Transcriptional targeting of DCs with lentiviral vectors induces antigen-specific tolerance in a mouse model of multiple sclerosis.Fungal infection in cerebrospinal fluid from some patients with multiple sclerosis.T cells specific for post-translational modifications escape intrathymic tolerance induction.Interferon-β regulates the production of IL-10 by toll-like receptor-activated microglia.Multiple sclerosis: Serum-derived exosomes express myelin proteins.Contribution of GPR30 for 1,25 dihydroxyvitamin D₃ protection in EAE.MerTK-mediated regulation of myelin phagocytosis by macrophages generated from patients with MS.Shuttling Tolerogenic Dendritic Cells across the Blood-Brain Barrier In Vitro via the Introduction of De Novo C-C Chemokine Receptor 5 Expression Using Messenger RNA Electroporation.Mechanisms of tolerance.Allogeneic hematopoietic stem cell transplantation for neuromyelitis opticaRole of Natural Killer Cells in Multiple Sclerosis
P2860
Q27023735-B34E7D3C-24CC-4FE3-A6ED-DAD163601102Q28393579-84FBA38F-2F1A-4DB0-A4E8-E7002D92D3A3Q29010983-72E7AE1F-7F98-499B-92CF-5FD94BFBF964Q33934590-C5A927CB-7DA1-4A37-8149-8783BE1A7FADQ34128679-42741CF4-7AB7-4248-A842-909A87327E64Q34427704-CFA3F375-9B48-4D37-95A5-3316A96BED93Q36069652-B2224564-4F86-41BA-AB76-08B86FF555F8Q36506677-78CD5EC9-228F-4697-9380-6CFFAD95382BQ36635630-158D747D-0D7E-4C53-A562-A774D513867EQ36719265-AEEE0DD4-4FCD-4299-869E-A151265D2866Q37141070-A06AEA50-6B8A-43A8-BE99-F17502E6A474Q37505364-A2B3AE66-8E26-4D8E-ACC3-EB2AB70A4B6DQ37559970-B1E5D17E-7DE0-45C7-A037-9B7369E86897Q37589284-10232193-719B-4AAC-9473-561C28E384CCQ37652166-C2982F42-A5E8-41E0-B5BE-A321EB3969FEQ37653497-5521D0D8-BB06-4F74-BE19-8EF3E204A451Q37997045-6B0BEC03-E993-4F65-94AD-16AAC9D52F38Q38008365-7941B46C-6161-4FB2-A653-9301634822ECQ38079579-BE56E389-F22B-40BC-AEB8-82B6D132DC47Q38111620-45975CEA-7809-4625-8EDB-D93F1E14DC5DQ38154948-829D7587-3500-4E01-9741-ABD41F3DC42AQ39021916-A3CA5182-D62E-4D23-998C-DDA5F0C3C6FCQ39149422-359489A9-CC0F-4EA1-BA84-836F7B3E1D6DQ39150957-B5490ECE-60D9-496A-ADD2-71FDD8B8A103Q40507582-3B6E76DD-41A0-4FB7-8925-C0EB4DC91DEBQ40541873-3705010E-CF23-4E97-A832-F91D56DC1D82Q42157420-61099A37-01C3-4CE7-9536-DE888A95FCABQ43293662-BD6EDD12-4911-4E4C-ACA0-E3B946C5DE61Q44129666-72409DE9-F555-404C-AE31-F4F3A43BCC0BQ45690450-97B5B439-A70E-4949-9B02-D0A69A6B5EA1Q48171859-99C18CC7-017E-4C4D-ABD5-1776615F532AQ48272369-F03C75DD-546F-43D9-B091-E44C01D24D04Q48568232-ADD35E01-FDC6-4C7E-ABCD-F7B7EE35AA6EQ48846709-836D0F0E-5EA1-496C-AA34-30D2E959B27AQ49590575-DA7C9D3E-CB06-4AA2-83BB-E24C9F9FD5BCQ49906660-FF1A65B3-BF82-4090-871A-A08C8D6E43F7Q53906830-655D32C5-44E2-4469-934B-DA2173D8E5CEQ57267894-40049A6C-638B-4435-9637-08CD0BF75642Q58692418-34570822-78CE-4EEE-BBED-FF10CAA9EE2A
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Immune tolerance in multiple sclerosis.
@ast
Immune tolerance in multiple sclerosis.
@en
Immune tolerance in multiple sclerosis.
@nl
type
label
Immune tolerance in multiple sclerosis.
@ast
Immune tolerance in multiple sclerosis.
@en
Immune tolerance in multiple sclerosis.
@nl
prefLabel
Immune tolerance in multiple sclerosis.
@ast
Immune tolerance in multiple sclerosis.
@en
Immune tolerance in multiple sclerosis.
@nl
P2860
P1476
Immune tolerance in multiple sclerosis
@en
P2093
Joan M Goverman
P2860
P304
P356
10.1111/J.1600-065X.2011.01016.X
P577
2011-05-01T00:00:00Z